Semerjian New Patient Conversion — Department of Urology
Patient Conversion — Semerjian vs. Other Surgeon vs. No OR
Surgery Location Split
Surgery Location by Month
Monthly Detail
Month
New Pts
Semerjian
Other
No OR
Chelsea
UH
Yield
Lag Bias Note: Dec 2025 and Jan 2026 may understate true surgical yield. Use "Mature Only" to exclude. Feb–Mar 2026 excluded entirely.
Key Insight: Semerjian operates primarily at Chelsea (64.1%) and UH (35.9%). When patients convert with other surgeons, 80.7% go to UH — reflecting subspecialty referral patterns within the department.
Methodology: Each new patient clinic visit matched to subsequent OR cases by MRN. Surgery location reflects the site of the first subsequent OR case.